Editas Medicine Inc (EDIT)
1.23
+0.02
(+1.65%)
USD |
NASDAQ |
Dec 26, 16:00
1.25
+0.02
(+1.63%)
After-Hours: 20:00
Editas Medicine Cash from Investing (Quarterly): 83.98M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
Ionis Pharmaceuticals Inc | -340.80M |
EyePoint Pharmaceuticals Inc | 16.20M |
Cassava Sciences Inc | -0.017M |
Adverum Biotechnologies Inc | -13.35M |
Regenxbio Inc | 50.26M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -52.59M |
Free Cash Flow | -191.36M |
Free Cash Flow Per Share (Quarterly) | -0.673 |
Free Cash Flow to Equity (Quarterly) | -55.51M |
Free Cash Flow Yield | -187.1% |